Viral Vectors Industry: Global Market Opportunities and Forecast 2021-2027
Report Code: KNJ1014997 No. of Pages: 128 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report provides a comprehensive analysis of current global Viral Vectors market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Viral Vectors industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to this survey, the global Viral Vectors market is estimated to have reached $ million in 2020, and projected to grow at a CAGR of % to $ million by 2027.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Viral Vectors Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Viral Vectors market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global Viral Vectors Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Viral Vectors industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Herpes Simplex Virus Vectors
Chimeric Viral Vectors
Others
Segmented by Application
Cancers
Inherited Disorders
Viral Infections
Others
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
VGXI
UniQure
Thermo Fisher Scientific (Brammer Bio)
Richter-Helm
PlasmidFactory
Oxford BioMedica
MolMed
MassBiologics
Lonza
FUJIFILM Diosynth Biotechnologies
FinVector
Eurogentec
Cobra Biologics
Cell and Gene Therapy Catapult
Biovian
BioReliance
Aldevron
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Viral Vectors Market Status and Forecast (2016-2027)
1.3.2 Global Viral Vectors Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Viral Vectors Supply by Company
2.1 Global Viral Vectors Sales Value by Company
2.2 Viral Vectors Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Viral Vectors Market Status by Type
3.1 Viral Vectors Type Introduction
3.1.1 Retroviral Vectors
3.1.2 Lentiviral Vectors
3.1.3 Adenoviral Vectors
3.1.4 Herpes Simplex Virus Vectors
3.1.5 Chimeric Viral Vectors
3.1.6 Others
3.2 Global Viral Vectors Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Viral Vectors Market Status by Application
4.1 Viral Vectors Segment by Application
4.1.1 Cancers
4.1.2 Inherited Disorders
4.1.3 Viral Infections
4.1.4 Others
4.2 Global Viral Vectors Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Viral Vectors Market Status by Region
5.1 Global Viral Vectors Market by Region
5.2 North America Viral Vectors Market Status
5.3 Europe Viral Vectors Market Status
5.4 Asia Pacific Viral Vectors Market Status
5.5 Central & South America Viral Vectors Market Status
5.6 Middle East & Africa Viral Vectors Market Status
6 North America Viral Vectors Market Status
6.1 North America Viral Vectors Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Viral Vectors Market Status
7.1 Europe Viral Vectors Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Viral Vectors Market Status
8.1 Asia Pacific Viral Vectors Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Viral Vectors Market Status
9.1 Central & South America Viral Vectors Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Viral Vectors Market Status
10.1 Middle East & Africa Viral Vectors Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Viral Vectors Market Forecast by Type and by Application
12.1 Global Viral Vectors Sales Value Forecast (2022-2027)
12.2 Global Viral Vectors Forecast by Type
12.3 Global Viral Vectors Forecast by Application
13 Global Viral Vectors Market Forecast by Region/Country
13.1 Global Viral Vectors Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 VGXI
14.1.1 Company Information
14.1.2 Viral Vectors Product Introduction
14.1.3 VGXI
Viral Vectors Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 UniQure
14.2.1 Company Information
14.2.2 Viral Vectors Product Introduction
14.2.3 UniQure
Viral Vectors Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Thermo Fisher Scientific (Brammer Bio)
14.3.1 Company Information
14.3.2 Viral Vectors Product Introduction
14.3.3 Thermo Fisher Scientific (Brammer Bio)
Viral Vectors Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Richter-Helm
14.4.1 Company Information
14.4.2 Viral Vectors Product Introduction
14.4.3 Richter-Helm
Viral Vectors Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 PlasmidFactory
14.5.1 Company Information
14.5.2 Viral Vectors Product Introduction
14.5.3 PlasmidFactory
Viral Vectors Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Oxford BioMedica
14.6.1 Company Information
14.6.2 Viral Vectors Product Introduction
14.6.3 Oxford BioMedica
Viral Vectors Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 MolMed
14.7.1 Company Information
14.7.2 Viral Vectors Product Introduction
14.7.3 MolMed
Viral Vectors Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 MassBiologics
14.8.1 Company Information
14.8.2 Viral Vectors Product Introduction
14.8.3 MassBiologics
Viral Vectors Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Lonza
14.9.1 Company Information
14.9.2 Viral Vectors Product Introduction
14.9.3 Lonza
Viral Vectors Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 FUJIFILM Diosynth Biotechnologies
14.10.1 Company Information
14.10.2 Viral Vectors Product Introduction
14.10.3 FUJIFILM Diosynth Biotechnologies
Viral Vectors Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 FinVector
14.12 Eurogentec
14.13 Cobra Biologics
14.14 Cell and Gene Therapy Catapult
14.15 Biovian
14.16 BioReliance
14.17 Aldevron
15 Conclusion
16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com